Head-to-head · Cost-Efficiency Index
Alinwell vs GoodRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Alinwell
Readers who want to see the compounding certificates before they buy, and who will look past the advertised figure to the price that renews.
Visit AlinwellGoodRx
Cost-first shoppers who want self-pay access to brand-name Zepbound without a compounded product.
Visit GoodRxThe verdict
Alinwell takes it, leading the Cost-Efficiency Index 57 to 56. Alinwell markets compounded GLP-1s to women from $149 a month, but that figure is a first-month discount: the standing rates are $249 for semaglutide and $299 for tirzepatide, and neither appears until checkout. GoodRx still earns a C — Cost-first shoppers who want self-pay access to brand-name Zepbound without a compounded product.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Alinwell.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Alinwell | GoodRx |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 56/100 |
| Semaglutide / mo | $249/mo month-to-month (charged every 30 days; the advertised $149 is the first month only) | Not disclosed |
| Tirzepatide / mo | $299/mo month-to-month (charged every 30 days; the advertised $199 is the first month only) | $299/mo (brand Zepbound, contract term) |
| Semaglutide / yr (modeled) | $2,988 | — |
| Tirzepatide / yr (modeled) | $3,588 | $3,588 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #316 | #323 |
Alinwell
57/100Where the value is
- Links a certificate of analysis for each GLP-1 from the treatment page itself, naming the compounding pharmacy, the strength and the testing laboratory
- The monthly figure includes physician review, care coaching, a dietitian visit and expedited shipping, with no separate consultation or dose-change fee
- Three- and six-month rates are shown side by side at checkout rather than being quoted only on request
The tradeoffs
- Every advertised price is an introductory one: "from $149/mo" and "from $199/mo" are labeled "$100 off first month" at checkout, with $249 and $299 struck through beside them
- The three-month plan costs more per month than the advertised monthly figure ($219 against $149), because the advertised figure was never a rate
GoodRx
56/100Where the value is
- Real FDA-approved brand medication, not compounded
- 70,000+ pharmacy redemption network under the Lilly self-pay partnership
- No membership fee — bring a prescription and use the card/program at the pharmacy counter
The tradeoffs
- Direct verification of goodrx.com was blocked in this research session (403 on every fetch) — the figure above is corroborated via indexed snippets and GoodRx's own press release, not a page personally read live; a follow-up direct check is advisable
- GoodRx is a discount/self-pay card, not a prescriber — a clinician visit is still required separately
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.